← Back to Search

Contact Lens

Test Contact Lens, Then Control Contact Lens for Near-sightedness

N/A

Waitlist Available

Led By Katherine Bickle

Research Sponsored by Coopervision, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 days of wear

Awards & highlights

Study Summary

This trial looks at how two types of soft contact lenses compare in comfort and vision.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 days of wear

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 days of wear

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 days of wear for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lens Handling on Removal

Trial Design

2Treatment groups

Experimental Treatment

Group I: Test Contact Lens, Then Control Contact LensExperimental Treatment2 Interventions

Participants will wear test contact lenses for one week and then crossover to control contact lenses for one week.

Group II: Control Contact Lens, Then Test Contact LensExperimental Treatment2 Interventions

Participants will wear control contact lenses for one week and then crossover to test contact lenses for one week.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Test Contact Lens (senofilcon A)

2023

N/A

~60

Control Contact Lens (stenfilcon A)

2023

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre for Ocular Research & Education, CanadaOTHER

10 Previous Clinical Trials

2,235 Total Patients Enrolled

Coopervision, Inc.Lead Sponsor

155 Previous Clinical Trials

13,769 Total Patients Enrolled

COREUNKNOWN

10 Previous Clinical Trials

2,235 Total Patients Enrolled

Media Library

Control Contact Lens (stenfilcon A) (Contact Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05805059 — N/A

Near-sightedness Research Study Groups: Test Contact Lens, Then Control Contact Lens, Control Contact Lens, Then Test Contact Lens

Near-sightedness Clinical Trial 2023: Control Contact Lens (stenfilcon A) Highlights & Side Effects. Trial Name: NCT05805059 — N/A

Control Contact Lens (stenfilcon A) (Contact Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05805059 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must a person fulfill to be accepted into this research endeavor?

"To be considered for this clinical trial, near-sighted individuals who are between 18 and 35 years old can submit their application. A total of 60 people will ultimately be selected to partake in the study."

Answered by AI

Are seniors excluded from this research endeavor?

"This medical trial is only open to applicants between 18-35 years old. By contrast, there are 71 trials that cater exclusively for minors and 18 studies which focus on elderly patients."

Answered by AI

Are there any opportunities for individuals to participate in this experiment?

"As documented on clinicaltrials.gov, recruitment for this trial has already concluded and the study is not presently accepting new participants. This medical experiment was initially posted on April 7th 2023 and last updated on March 28th 2023. However, 105 other trials are actively seeking patients at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses.

2023. "Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05805059.